The ZYBULIN brand, founded in 2007 (United States), from
4 sister brands
and 2214 competing brands.
ZYBULIN is owned by Ziopharm Oncology, listed on the stock exchange of New York
ZYBULIN belongs to the Biotechnology business sector.
ZYBULIN is a brand of Ziopharm Oncology (TCRT) News
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.